Partnership with Predictiv to integrate anonymized Genetic data into its patent-pending algorithms
RICHARDSON, Texas–(BUSINESS WIRE)–InterGen Data, Inc. today announced a partnership with Predictiv to enhance its critical illness prediction capabilities. As part of this partnership, InterGen Data will integrate and utilize Predictiv’s fully anonymized next-generation DNA sequenced data to improve the accuracy of its Patent-Pending Life Stage/Life Event algorithms “LS/LE.”
“Over the last few years, the one thing that has startled everyone has been the cost of healthcare. Consumers have come to realize that their financial plans, risk models, and insurance policies just aren’t enough,” said Robert J. Kirk CEO of InterGen Data. Kirk further stated “Don’t misunderstand me … these systems and platforms do a really good job, but when it comes to unexpected events, chronic illnesses, and disability, they all rely on manual input. In other words, when someone plans to get Cancer, have a Heart Attack, or lose a loved one.”
“We are excited to partner with InterGen Data to further enhance their Critical Illness life event prediction models.” said Sajung Yun CEO of Predictiv. “Our data is based on the most advanced DNA next generation sequencing where we sequence all 20,000+ genes against all known diseases (22,000) as well as 45 of the most important medications,” Yun further stated.
According to a recent Kaiser Family Foundation (KFF) article “Americans’ Challenges with Health Care Costs” by Audrey Kearney, Liz Hamel, Mellisha Stokes, and Mollyann Brodie, healthcare costs top the list of expenses that people are having difficulty with. According to the study, people are more concerned with the ability to afford out-of-pocket healthcare costs then their rent or mortgage (see figure 1). This has also led to more than half of the respondents to skip or delay seeking proper healthcare.
InterGen Data, Inc. currently predicts 93 individual Life Events in two basic categories: Health and Wealth. These events include but are not limited to the following: Wealth (Marriages, Divorce, Cars, Homes, Children, Business, etc.) and Health (27 types of Cancer, 21 types of Heart issues, Brain, and Organ illnesses, etc.). InterGen Data can predict 12 wealth related life events with as little as 7 non personally identifiable information “PII” attributes and can predict 81 chronic illness events with 18 additional data attributes. Once modeled, the data produced includes information about what events are likely to happen, the year that these events have the highest probability of occurrence, and how much they could potentially impact one’s financial future (inflation adjusted).
Predictiv – Predictiv uses the most advanced DNA testing: next generation sequencing. We screen for the mutations or variations present in all your genes against all known diseases and the most important medications. Now you can make more informed decisions on your health. Predictiv uses their next-Generation Genetic Testing and Analysis to create a personalized digital twin where you can access genetic counseling and a healthcare concierge through their award-winning precision-medicine platform.
About InterGen Data, Inc.
InterGen Data, Inc. (InterGen Data) was founded by the financial services industry veteran Robert J. Kirk in December 2017. InterGen Data is an award-winning Life Event Data and Analysis provider that uses the latest in AI-based machine learning techniques and patent pending proprietary algorithms which can identify when someone is likely to have an important life event occur, what that event could be, and how much of an economic impact that it would have on their financial journey. They supply this data to banks, financial services, and insurance companies.
More information can be found at https://www.intergendata.com
About Predictiv
Predictiv was founded by recognized genomics experts, Sajung and Sijung Yun, Predictiv has been built on the academic expertise and the entrepreneurship experience that is required to change the way medicine is done today. The mission of Predictiv is simple – provide people the solution to have the absolute most happy, healthy, and long life. Predictiv plans to provide health and analytical data on virtually all aspects of health. While we are starting with genomic sequencing and genetic testing, we plan to launch a fully scaled health and medical data platform, which will also bring the world of nutrition and fitness into the future.
More information can be found at https://www.predictivcare.com
Forward-Looking Statements
This news release contains or refers to certain statements that we make may constitute “forward-looking statements” under the Private Securities Litigation Reform Act of 1995. Forward-looking statements include information concerning future strategic objectives, business prospects, anticipated savings, financial results (including expenses, earnings, liquidity, cash flow and capital expenditures), industry or market conditions, demand for and pricing of our products, acquisitions and divestitures, anticipated results of litigation and regulatory developments or general economic conditions. In addition, words such as “believes,” “expects,” “anticipates,” “intends,” “plans,” “estimates,” “projects,” “forecasts,” and future or conditional verbs such as “will,” “may,” “could,” “should,” and “would,” as well as any other statement that necessarily depends on future events, are intended to identify forward-looking statements. Forward-looking statements are not guarantees, and they involve risks, uncertainties, and assumptions. Although we make such statements based on assumptions that we believe to be reasonable, there can be no assurance that actual results will not differ materially from those expressed in the forward-looking statements. We expressly disclaim any obligation to update any forward-looking statement in the event it later turns out to be inaccurate, whether as a result of new information, future events or otherwise. Parts of this news release may also include additional information on forward-looking statements. This news release may also contain measures that are not calculated based on accounting principles generally accepted in the United States of America, or GAAP.
Contacts
Robert J. Kirk
Robert.kirk@intergendata.com
+1 (972) 833-2820
